Literature DB >> 16426332

Sirolimus-associated heavy proteinuria in a renal transplant recipient: evidence for a tubular mechanism.

L Straathof-Galema1, J F M Wetzels, H B P M Dijkman, E J Steenbergen, L B Hilbrands.   

Abstract

Sirolimus is a new and potent immunosuppressive agent. Recently, increased proteinuria has been recognized as an important complication. However, the mechanism thereof has remained unclear. We describe a patient who received sirolimus as standard therapy after living donor kidney transplantation. Within 10 days the patient developed a severe proteinuria that disappeared completely after substituting tacrolimus for sirolimus. Renal biopsy disclosed normal glomeruli even without effacement of the podocytic foot processes. Using FITC labeled anti-albumin antibodies we noted complete absence of albumin in the proximal tubules, whereas an abundant albumin staining was observed in a control patient with a comparable level of proteinuria due to a recurrence of focal segmental glomerulosclerosis after transplantation. Our data suggest that sirolimus can induce severe proteinuria, and that reduced tubular protein reabsorption contributes to the protein loss.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16426332     DOI: 10.1111/j.1600-6143.2005.01195.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  11 in total

1.  What counts in data mining?

Authors:  Manfred Hauben; Vaishali K Patadia; David Goldsmith
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  Role of Ragulator in the Regulation of Mechanistic Target of Rapamycin Signaling in Podocytes and Glomerular Function.

Authors:  Yao Yao; Junying Wang; Sei Yoshida; Shigeyuki Nada; Masato Okada; Ken Inoki
Journal:  J Am Soc Nephrol       Date:  2016-03-31       Impact factor: 10.121

3.  Urine high and low molecular weight proteins one-year post-kidney transplant: relationship to histology and graft survival.

Authors:  H Amer; J C Lieske; A D Rule; W K Kremers; T S Larson; C R Franco Palacios; M D Stegall; F G Cosio
Journal:  Am J Transplant       Date:  2013-02-15       Impact factor: 8.086

4.  Recurrent glomerulonephritis under rapid discontinuation of steroids.

Authors:  Aleksandra Kukla; Eric Chen; Richard Spong; Marc Weber; Yasser El-Shahawi; Kristen Gillingham; Arthur J Matas; Hassan N Ibrahim
Journal:  Transplantation       Date:  2011-06-27       Impact factor: 4.939

5.  Stable renal function after islet transplantation: importance of patient selection and aggressive clinical management.

Authors:  Cristiane B Leitão; Pablo Cure; Shari Messinger; Antonello Pileggi; Oliver Lenz; Tatiana Froud; Raquel N Faradji; Gennaro Selvaggi; Warren Kupin; Camillo Ricordi; Rodolfo Alejandro
Journal:  Transplantation       Date:  2009-03-15       Impact factor: 4.939

Review 6.  Mechanisms and management of proteinuria in kidney transplant patients.

Authors:  Azemi A Barama
Journal:  Drugs       Date:  2008       Impact factor: 9.546

7.  Renal cortex neuronal nitric oxide synthase in response to rapamycin in kidney transplantation.

Authors:  You-Lin Tain; Veronika Muller; Attila J Szabo; Aaron Erdely; Cheryl Smith; Chris Baylis
Journal:  Nitric Oxide       Date:  2007-10-12       Impact factor: 4.427

Review 8.  Sirolimus-associated proteinuria and renal dysfunction.

Authors:  Gopala K Rangan
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

9.  Proteinuria and baseline renal function predict mortality and renal outcomes after sirolimus therapy in liver transplantation recipients.

Authors:  Lung-Chih Li; Chien-Ning Hsu; Chih-Che Lin; Yu-Fan Cheng; Tsung-Hui Hu; Ding-Wei Chen; Chih-Hsiung Lee; Toshiaki Nakano; Chao-Long Chen
Journal:  BMC Gastroenterol       Date:  2017-04-20       Impact factor: 3.067

10.  Conversion to sirolimus ameliorates cyclosporine-induced nephropathy in the rat: focus on serum, urine, gene, and protein renal expression biomarkers.

Authors:  José Sereno; Sara Nunes; Paulo Rodrigues-Santos; Helena Vala; Petronila Rocha-Pereira; João Fernandes; Alice Santos-Silva; Frederico Teixeira; Flávio Reis
Journal:  Biomed Res Int       Date:  2014-05-19       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.